UnknownNCT05579236

Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease

Studying Early-onset autosomal dominant Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital Southampton NHS Foundation Trust
Principal Investigator
Christopher Kipps, PhD
University Hospital Southampton NHS Foundation Trust
Enrollment
400 target
Eligibility
50-90 years · All sexes
Timeline
20222025

Study locations (3)

Collaborators

University of Southampton · Oxford Brain Diagnostics Ltd · Cardiff and Vale University Health Board · Cardiff University · University of Oxford · Bournemouth University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05579236 on ClinicalTrials.gov

Other trials for Early-onset autosomal dominant Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for Early-onset autosomal dominant Alzheimer disease

← Back to all trials